Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F

by Pastore, Friederike, Schneider, Stephanie, Christ, Oliver, Hiddemann, Wolfgang, Spiekermann, Karsten
Published 2013

The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML

by Pastore, Friederike, Pastore, Alessandro, Wittmann, Georg, Hiddemann, Wolfgang, Spiekermann, Karsten
Published 2014

Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia

by Janke, Hanna, Pastore, Friederike, Schumacher, Daniela, Herold, Tobias, Hopfner, Karl-Peter, Schneider, Stephanie, Berdel, Wolfgang E., Büchner, Thomas, Woermann, Bernhard J., Subklewe, Marion, Bohlander, Stefan K., Hiddemann, Wolfgang, Spiekermann, Karsten, Polzer, Harald
Published 2014

Long-term follow-up of cytogenetically normal CEBPA-mutated AML

by Pastore, Friederike, Kling, Daniela, Hoster, Eva, Dufour, Annika, Konstandin, Nikola P, Schneider, Stephanie, Sauerland, Maria C, Berdel, Wolfgang E, Buechner, Thomas, Woermann, Bernhard, Braess, Jan, Hiddemann, Wolfgang, Spiekermann, Karsten
Published 2014

The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML

by Pastore, Friederike, Greif, Philipp A., Schneider, Stephanie, Ksienzyk, Bianka, Mellert, Gudrun, Zellmeier, Evelyn, Braess, Jan, Sauerland, Cristina M., Heinecke, Achim, Krug, Utz, Berdel, Wolfgang E., Buechner, Thomas, Woermann, Bernhard, Hiddemann, Wolfgang, Spiekermann, Karsten
Published 2014